文献速递炎症性肠病消化内镜

遗传与炎症生物标志物可识别克罗恩病无症状一级亲属的小肠炎症

Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-06-14

研究纳入480名克罗恩病健康一级亲属,基于72个遗传变异、家族史和吸烟计算风险评分,用胶囊内镜和22种粪便/血清炎症标志物评估症状前炎症,机器学习分类器可识别小肠炎症,弹性网AUC 0.80,随机森林AUC 0.87;联合家族史、遗传风险评分和粪钙卫蛋白可计算炎症 odds。

要点

  • 机器学习分类器可识别克罗恩病无症状一级亲属的症状前小肠炎症。
  • 弹性网识别3个变量计算炎症 odds:合并家族史 OR 1.31、遗传风险评分 OR 1.14、粪钙卫蛋白 OR 1.04。
  • 随机森林模型中上述3个变量也在与小肠炎症相关的5个因素之列。

核心结论

  • 与克罗恩病相关的遗传变异、家族史和粪钙卫蛋白联合可识别症状前小肠炎症个体,这些个体有克罗恩病风险。

研究设计与样本

  • 通过Guy's and St Thomas' NHS Foundation Trust和英国Crohn's and Colitis成员招募480名克罗恩病患者健康一级亲属(全同胞、子代或父母)。
  • 使用Immunochip对DNA样本进行基因分型,基于72个与克罗恩病相关的遗传变异、家族史和吸烟史计算454名参与者的风险评分。
  • 参与者被分配到风险评分最高和最低四分位组,通过胶囊内镜评估症状前炎症,并测量粪便和血清样本中22种炎症标志物作为参考标准。
  • 使用两种机器学习分类器(弹性网和随机森林)评估风险因素和生物标志物在同一数据集中识别小肠炎症参与者的能力。

主要发现

  • 机器学习分类器识别症状前肠道炎症:弹性网AUC 0.80(95% CI 0.62-0.98),随机森林AUC 0.87(95% CI 0.75-1.00)。
  • 弹性网方法识别3个变量用于计算肠道炎症 odds:合并克罗恩病家族史 OR 1.31,遗传风险评分 OR 1.14,粪钙卫蛋白 OR 1.04。
  • 随机森林模型中,同样的3个变量在与肠道炎症相关的5个因素之列。

关键数值与推荐

  • 弹性网识别用于计算肠道炎症 odds 的变量:合并家族史 OR 1.31,遗传风险评分 OR 1.14,粪钙卫蛋白 OR 1.04。

临床怎么用

  • 在克罗恩病无症状一级亲属中,联合遗传风险评分、家族史和粪钙卫蛋白可能用于识别症状前小肠炎症个体。
  • 在症状出现前识别克罗恩病风险个体,可能有助于确定最可能从早期干预中获益的个体。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Relatives of individuals with Crohn's disease (CD) carry CD-associated genetic variants and are often exposed to environmental factors that increase their risk for this disease. We aimed to estimate the utility of genotype, smoking status, family history, and biomarkers can calculate risk in asymptomatic first-degree relatives of patients with CD. METHODS: We recruited 480 healthy first-degree relatives (full siblings, offspring or parents) of patients with CD through the Guy's and St Thomas' NHS Foundation Trust and from members of Crohn's and Colitis, United Kingdom. DNA samples were genotyped using the Immunochip. We calculated a risk score for 454 participants, based on 72 genetic variants associated with CD, family history, and smoking history. Participants were assigned to highest and lowest risk score quartiles. We assessed pre-symptomatic inflammation by capsule endoscopy and measured 22 markers of inflammation in stool and serum samples (reference standard). Two machine-learning classifiers (elastic net and random forest) were used to assess the ability of the risk factors and biomarkers to identify participants with small intestinal inflammation in the same dataset. RESULTS: The machine-learning classifiers identified participants with pre-symptomatic intestinal inflammation: elastic net (area under the curve, 0.80; 95% CI, 0.62-0.98) and random forest (area under the curve, 0.87; 95% CI, 0.75-1.00). The elastic net method identified 3 variables that can be used to calculate odds for intestinal inflammation: combined family history of CD (odds ratio, 1.31), genetic risk score (odds ratio, 1.14), and fecal calprotectin (odds ratio, 1.04). These same 3 variables were among the 5 factors associated with intestinal inflammation in the random forest model. CONCLUSION: Using machine learning classifiers, we found that genetic variants associated with CD, family history, and fecal calprotectin together identify individuals with pre-symptomatic intestinal inflammation who are therefore at risk for CD. A tool for detecting people at risk for CD before they develop symptoms would help identify the individuals most likely to benefit from early intervention.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Taylor KM, Hanscombe KB, Prescott NJ, et al. Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2019. PMID: 31202982. doi:10.1016/j.cgh.2019.05.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。